BioHealth News
Adaptive Phage Therapeutics CEO Greg Merril and His Father’s Journey Highlighted in BBC StoryWorks’ Documentary, ‘Race Against Resistance’
The documentary-style film addresses the urgent global health crisis of antimicrobial resistance, which is causing widespread concern in the scientific and medical fields. The…
Read More
Seize Opportunities at the 6th Annual BioHealth Capital Region Investment Conference: Applications Due September 12th
Your Invitation to apply to a Key Investment Event in Rockville, Maryland Awaits There's still time if you haven't yet marked your calendar for…
Read More
Still Time to Register: Unlock Collaboration at the 9th Annual BioHealth Capital Region Forum
Your Invitation to a Pivotal BioHealth Event in Rockville, Maryland Awaits If you haven't yet marked your calendar for the 9th Annual BioHealth Capital…
Read More
BIO Podcast Episode 87: The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab?
The horseshoe crab has endured for over 450 million years.In this episode we talk with three experts about how this animal’s unique blue blood…
Read More
PM Live: GSK invests over $270m in vaccine manufacturing ahead of RSV vaccine launch
GSK has announced it is investing over £270m to build a new vaccine manufacturing facility at its Wavre campus in Belgium. The investment follows…
Read More
VLP Therapeutics group announces 2nd closing of funding to develop cancer, infectious disease vaccines, establish investigational vaccine manufacturing facility
US-based biotech company VLP Therapeutics, Inc. (VLPT) and its Tokyo-based group company VLP Therapeutics Japan, Inc. (VLPT Japan) together announced on September 5 the…
Read More
Rockville’s MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
ROCKVILLE, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics…
Read More
Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO
Join us for an insightful episode of BioTalk as host Rich Bendis welcomes back Rachel King, the visionary CEO of the Biotechnology Innovation Organization…
Read More
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
GAITHERSBURG, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and…
Read More
MedCityNews: Washington D.C.’s Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B
Danaher’s wide-ranging offerings for the life sciences sector will get broader and deeper with the $5.7 billion acquisition of Abcam, a company that makes reagents…
Read More
Lupus Foundation of America and Lupus Canada Award Grant for Study Examining New Method to Predict Treatment Response in Lupus Nephritis to Improve Kidney Outcomes
WASHINGTON, Aug. 28, 2023 /PRNewswire/ -- The Lupus Foundation of America and Lupus Canada are pleased to announce Joan Wither, MD, PhD, FRCPC has been awarded the 2023…
Read More
CellKey, a BHI Partner Company, Emerald Cloud Lab (ECL) Partner to Co-Develop Advanced Glycoprotein Analysis Platform
Los Angeles, CA; September - CellKey, a leading provider of innovative bioanalytical solutions, is thrilled to announce the signing of a Memorandum of Understanding…
Read More
2023 Technology Showcase: A Hub for Biotech Innovation and Collaboration
The Frederick National Laboratory Advanced Technology Research Facility in Frederick, MD, is set to host the 2023 Technology Showcase on September 6, 2023. This…
Read More
TEDCO Announces SSBCI Investment in Polaris Genomics
Maryland-based veteran-owned biotech company is working to transform mental health care COLUMBIA, Md. (August 28, 2023) – Charles Cathlin, CEO of Polaris Genomics (TEDCO…
Read More
The BioHealth Capital Region’s Adaptive Phage Therapeutics lands on Fierce Biotech’s Fierce 15
It’s been a tough year for biotech, so how about a little good news? In between all the layoffs, restructurings and last-ditch strategic option…
Read More